These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 32345243)

  • 61. Early versus late delayed percutaneous coronary intervention in elderly patients with ST-segment elevation myocardial infarction.
    Lang J; Wang C; Zhang J; Hu Y; Wang L; Liu Y; Xu R; Wu J; Qi W; Liu C; Li W; Li T; Jin D; Wei A; Wang L; Cong H
    Aging Clin Exp Res; 2023 Jun; 35(6):1317-1324. PubMed ID: 37171538
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Impact of COVID-19 on percutaneous coronary intervention for ST-elevation myocardial infarction.
    Kwok CS; Gale CP; Kinnaird T; Curzen N; Ludman P; Kontopantelis E; Wu J; Denwood T; Fazal N; Deanfield J; de Belder MA; Mamas M
    Heart; 2020 Dec; 106(23):1805-1811. PubMed ID: 32868280
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Association Between Cardiac Catheterization Laboratory Pre-Activation and Reperfusion Timing Metrics and Outcomes in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: A Report From the ACTION Registry.
    Shavadia JS; Roe MT; Chen AY; Lucas J; Fanaroff AC; Kochar A; Fordyce CB; Jollis JG; Tamis-Holland J; Henry TD; Bagai A; Kontos MC; Granger CB; Wang TY
    JACC Cardiovasc Interv; 2018 Sep; 11(18):1837-1847. PubMed ID: 30236357
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Relationship between White Blood Count to Mean Platelet Volume Ratio and Clinical Outcomes and Severity of Coronary Artery Disease in Patients Undergoing Primary Percutaneous Coronary Intervention.
    Emre AR; Yasar KA; Atakan Y; Orhan C; Murathan K
    Cardiovasc Ther; 2020; 2020():9625181. PubMed ID: 32934665
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Intensive Care Utilization in Stable Patients With ST-Segment Elevation Myocardial Infarction Treated With Rapid Reperfusion.
    Shavadia JS; Chen AY; Fanaroff AC; de Lemos JA; Kontos MC; Wang TY
    JACC Cardiovasc Interv; 2019 Apr; 12(8):709-717. PubMed ID: 31000008
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Prasugrel or ticagrelor relative to clopidogrel in triple-antiplatelet treatment combined with glycoprotein IIb/IIIa inhibitor for patients with STEMI undergoing PCI: a meta-analysis.
    Wang Z; Zhou DY; Su Y; Si LY; Xu Q
    BMC Cardiovasc Disord; 2020 Mar; 20(1):130. PubMed ID: 32164560
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Comparison of direct stenting with conventional strategy on myocardial impairments in ST-segment elevation myocardial infarction: a cardiac magnetic resonance imaging study.
    He J; Kong LC; Zeng JT; Shi BZ; An DA; Chen BH; Ding S; Li Z; Yang F; Yang YN; Yan FH; Xiu JC; Wang HW; Xu JR; Ge H; Pu J
    Int J Cardiovasc Imaging; 2020 Jun; 36(6):1167-1175. PubMed ID: 32166507
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Safety and efficacy of regional transport combined with PCI model in patients with STEMI after thrombolysis in northwest China].
    Bai M; Pan CL; Zhao J; Zhao CR; Zhang B; Mu ZY; Meng XX; Zhou XH; Zhu YQ; Zhang Z
    Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Aug; 48(8):641-647. PubMed ID: 32847319
    [No Abstract]   [Full Text] [Related]  

  • 69. Impact of previous percutaneous coronary intervention on angiographic and clinical outcomes in patients with ST-segment elevation myocardial infarction.
    de Cossío AS; Araiza-Garaygordobil D; Nájera-Rojas NA; Alonso-Bringas AP; Robles-Ledesma M; la Cruz JLB; Gopar-Nieto R; González-Pacheco H; Sierra-Lara-Martínez D; Arias-Mendoza A
    Gac Med Mex; 2024; 160(1):45-52. PubMed ID: 38753565
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Clinical Outcomes One Year and Beyond After Combination Sirolimus-Eluting Endothelial Progenitor Cell Capture Stenting During Primary Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial Infarction.
    Sim HW; Thong EH; Tan HC; Low AF; Lee CH; Chan MY; Tay EL; Loh PH; Chan KH; Loh JP
    Cardiovasc Revasc Med; 2019 Sep; 20(9):739-743. PubMed ID: 30442536
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Circadian dependence of manual thrombus aspiration benefit in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Fournier S; Muller O; Benedetto U; Roffi M; Pilgrim T; Eberli FR; Rickli H; Radovanovic D; Erne P; Cook S; Noble S; Fesselet R; Zuffi A; Degrauwe S; Masci P; Windecker S; Eeckhout E; Iglesias JF;
    Clin Res Cardiol; 2018 Apr; 107(4):338-346. PubMed ID: 29222592
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Effect of intracoronary agents on the no-reflow phenomenon during primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction: a network meta-analysis.
    Niu X; Zhang J; Bai M; Peng Y; Sun S; Zhang Z
    BMC Cardiovasc Disord; 2018 Jan; 18(1):3. PubMed ID: 29320987
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Outcomes after ST-elevation myocardial infarction presentation to hospitals with or without a routine primary percutaneous coronary intervention service (ANZACS-QI 46).
    Lee S; Miller R; Lee M; White H; Kerr A
    N Z Med J; 2020 Oct; 133(1524):64-81. PubMed ID: 33119571
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Fragmented QRS (fQRS) Complex Predicts Adverse Cardiac Events of ST-Segment Elevation Myocardial Infarction Patients Undergoing Percutaneous Coronary Intervention and Thrombolysis.
    Xia W; Feng XY
    Med Sci Monit; 2018 Jul; 24():4634-4640. PubMed ID: 29974889
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Chronic kidney disease and the outcomes of fibrinolysis for ST-segment elevation myocardial infarction: A real-world study.
    Xie W; Patel A; Boersma E; Feng L; Li M; Gao R; Wu Y
    PLoS One; 2021; 16(1):e0245576. PubMed ID: 33465135
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The contemporary management and coronary angioplasty outcomes in young patients with ST-Elevation myocardial infarction (STEMI) age < 40 years old: the insight from nationwide Thai PCI registry.
    Porapakkham P; Porapakkham P; Srimahachota S; Limpijankit T; Kiatchoosakun S; Chandavimol M; Kanoksilp A; Chantadansuwan T; Thakkinstian A; Sansanayudh N
    BMC Cardiovasc Disord; 2024 Oct; 24(1):548. PubMed ID: 39390373
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Determinants of excess mortality following unprotected left main stem percutaneous coronary intervention.
    Alabas OA; Brogan RA; Hall M; Almudarra S; Rutherford MJ; Dondo TB; Feltbower R; Curzen N; de Belder M; Ludman P; Gale CP;
    Heart; 2016 Aug; 102(16):1287-95. PubMed ID: 27056968
    [TBL] [Abstract][Full Text] [Related]  

  • 78. COVID-19 pandemic is associated with mechanical complications in patients with ST-elevation myocardial infarction.
    Kitahara S; Fujino M; Honda S; Asaumi Y; Kataoka Y; Otsuka F; Nakanishi M; Tahara Y; Ogata S; Onozuka D; Nishimura K; Fujita T; Tsujita K; Ogawa H; Noguchi T
    Open Heart; 2021 Feb; 8(1):. PubMed ID: 33547221
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Impact of acute glycemic variability on short-term outcomes in patients with ST-segment elevation myocardial infarction: a multicenter population-based study.
    Wang J; Wang LL; Yang YM; Tan HQ; Zhu J
    Cardiovasc Diabetol; 2024 May; 23(1):155. PubMed ID: 38715023
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Impact of symptom onset to first medical contact time on the prognosis of patients with acute ST-segment elevation myocardial infarction].
    Wei TF; Zhao B; Liu PL; Feng XY; Zhang Z; Shi QX; Gao TS; Liu L; Zhao JT; Song HY; Liu LF; Liu YQ; Rao MM; Wang SL
    Zhonghua Xin Xue Guan Bing Za Zhi; 2017 May; 45(5):393-398. PubMed ID: 28511323
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.